Literature DB >> 7555443

Influence of bradykinin in gastrointestinal disorders and visceral pain induced by acute or chronic inflammation in rats.

V Julia1, T Mezzasalma, L Buéno.   

Abstract

This work investigated the role of bradykinin in viscerosensitivity before and during inflammation in two models of visceral pain induced by rectal distension (RD) or "abdominal distension" (AD) in rats. RD induced both inhibition of colonic motility and an increase of abdominal spike bursts. Bradykinin receptor antagonist, Hoe 140 did not affect any of the RD-induced responses. After TNB-induced rectal inflammation, colonic inhibition and the number of abdominal contractions were enhanced. Hoe 140 selectively reduced the abdominal response to the highest distension volume, without affecting the colonic response. In AD group, acetic acid inhibited gastric emptying and increased the number of abdominal contractions, whereas the same volume of saline did not affect any of the responses. Before inflammation, Hoe 140 (1-5 mg/kg, intraperitoneally) did not affect per se abdominal and gastric emptying responses; in contrast, at 5 mg/kg, intraperitoneally, it reduced significantly (P < 0.05) both acetic acid-induced responses. We conclude that bradykinin is involved in viscerosensitivity changes related to abdominal and rectal distension in inflammatory conditions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7555443     DOI: 10.1007/bf02208656

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  31 in total

Review 1.  Bradykinin antagonists.

Authors:  J M Bathon; D Proud
Journal:  Annu Rev Pharmacol Toxicol       Date:  1991       Impact factor: 13.820

2.  Simultaneous release by bradykinin of substance P- and calcitonin gene-related peptide immunoreactivities from capsaicin-sensitive structures in guinea-pig heart.

Authors:  P Geppetti; C A Maggi; F Perretti; S Frilli; S Manzini
Journal:  Br J Pharmacol       Date:  1988-06       Impact factor: 8.739

3.  Antinociceptive effects of bradykinin antagonists.

Authors:  L R Steranka; C J DeHaas; R J Vavrek; J M Stewart; S J Enna; S H Snyder
Journal:  Eur J Pharmacol       Date:  1987-04-14       Impact factor: 4.432

4.  Bradykinin is increased during acute and chronic inflammation: therapeutic implications.

Authors:  K M Hargreaves; E S Troullos; R A Dionne; E A Schmidt; S C Schafer; J L Joris
Journal:  Clin Pharmacol Ther       Date:  1988-12       Impact factor: 6.875

5.  Bradykinin and oedema formation in heated paws of rats.

Authors:  M S Starr; G B West
Journal:  Br J Pharmacol Chemother       Date:  1967-09

Review 6.  Bradykinin and inflammatory pain.

Authors:  A Dray; M Perkins
Journal:  Trends Neurosci       Date:  1993-03       Impact factor: 13.837

7.  Evidence for a role of bradykinin in experimental pain models.

Authors:  T T Chau; A C Lewin; T L Walter; R P Carlson; B M Weichman
Journal:  Agents Actions       Date:  1991-09

8.  The effect of kinin agonists and antagonists on the pain response of the human blister base.

Authors:  E T Whalley; S Clegg; J M Stewart; R J Vavrek
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-12       Impact factor: 3.000

9.  Involvement of neurokinin 1 and 2 receptors in viscerosensitive response to rectal distension in rats.

Authors:  V Julia; O Morteau; L Buéno
Journal:  Gastroenterology       Date:  1994-07       Impact factor: 22.682

10.  Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro studies.

Authors:  F J Hock; K Wirth; U Albus; W Linz; H J Gerhards; G Wiemer; S Henke; G Breipohl; W König; J Knolle
Journal:  Br J Pharmacol       Date:  1991-03       Impact factor: 8.739

View more
  4 in total

1.  Actions of bradykinin on electrical and synaptic behavior of neurones in the myenteric plexus of guinea-pig small intestine.

Authors:  Hong-Zhen Hu; Sumei Liu; Na Gao; Yun Xia; Randa Mostafa; Jun Ren; Dimiter H Zafirov; Jackie D Wood
Journal:  Br J Pharmacol       Date:  2003-04       Impact factor: 8.739

2.  Bradykinin modulates pacemaker currents through bradykinin B2 receptors in cultured interstitial cells of Cajal from the murine small intestine.

Authors:  Seok Choi; Do Young Park; Cheol Ho Yeum; In Youb Chang; Ho Jin You; Chan Guk Park; Man Yoo Kim; In Deok Kong; Insuk So; Ki Whan Kim; Jae Yeoul Jun
Journal:  Br J Pharmacol       Date:  2006-06-19       Impact factor: 8.739

3.  Perceptual responses in patients with inflammatory and functional bowel disease.

Authors:  L Chang; J Munakata; E A Mayer; M J Schmulson; T D Johnson; C N Bernstein; L Saba; B Naliboff; P A Anton; K Matin
Journal:  Gut       Date:  2000-10       Impact factor: 23.059

4.  Inflammation and enhanced nociceptive responses to bladder distension produced by intravesical zymosan in the rat.

Authors:  Alan Randich; Tyler Uzzell; Ronda Cannon; Timothy J Ness
Journal:  BMC Urol       Date:  2006-02-09       Impact factor: 2.264

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.